Key Insights

Highlights

Treatment Research

3 treatments under study, led by Skin Biopsy

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Unknown2
Recruiting1

Clinical Trials (3)

Research Network

Common Treatments

  • Skin Biopsy1
  • Abdominal Wall Injections With Lidocaine 21
  • Sodium Channel Mutation1

Active Sponsors

  • Maxima Medical Center2
  • Oregon Health and Science University1

Top Investigators

Related Conditions

  • Chronic Pain Syndrome2
  • Nerve Entrapment Syndrome2
  • Diagnosis1

Activity Timeline